{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:07:08Z","timestamp":1757704028038},"reference-count":15,"publisher":"BMJ","issue":"6844","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1992,7,4]]},"DOI":"10.1136\/bmj.305.6844.39","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T12:16:37Z","timestamp":1238415397000},"page":"39-42","source":"Crossref","is-referenced-by-count":3,"title":["Non-Hodgkin's lymphoma. II: Management problems."],"prefix":"10.1136","volume":"305","author":[{"given":"S. E.","family":"O'Reilly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"1682","article-title":"Non-Hodgkin's lymphoma.l: characterisation and treatment","volume":"7","author":"O'Reilly, S.E.; Connors, J.M.","year":"1992","unstructured":"O'Reilly SE, Connors JM. Non-Hodgkin's lymphoma.l: characterisation and treatment. BIM 7 1992;304:1682-6.","journal-title":"BIM"},{"key":"ref_2","first-page":"1838","article-title":"rhe importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma","volume":"6","author":"Vose, J.M.; Armitage, J.O.; DI), Weisenburgcr; I'J, Bierman; Soreniscn, S.; Hutchins, M.","year":"1989","unstructured":"Vose JM, Armitage JO, Weisenburgcr DI), Bierman I'J, Soreniscn S, Hutchins M. rhe importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1989;6:1838-44.","journal-title":"J Clin Oncol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1200\/JCO.1991.9.5.741","article-title":"Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma","volume":"9","author":"O'Reilly, S.E.; Klimo, P.; Connors, J.M.","year":"1991","unstructured":"O'Reilly SE, Klimo P, Connors JM. Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma. J Clin Oncol 1991;9:741.","journal-title":"J Clin Oncol"},{"key":"ref_4","first-page":"326","article-title":"POCE chemotherapy-a phase II trial in cIderly patients with advanced stage diffuse large cell lymphoma","volume":"11","author":"O'Reilly, S.E.; Hoskins, P.; Howdle, S.; Klasa, R.; Klimo, P.; Stuart, D.","year":"1992","unstructured":"O'Reilly SE, Hoskins P, Howdle S, Klasa R, Klimo P, Stuart D, et al. POCE chemotherapy-a phase II trial in cIderly patients with advanced stage diffuse large cell lymphoma. Proceedings of the American Societv of Clinical Oncology 1992;11:326.","journal-title":"Proceedings of the American Societv of Clinical Oncology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/1097-0142(19800415)45:8<2188::AID-CNCR2820450830>3.0.CO;2-E","article-title":"Diffuse histiocytic lymphoma prcsenting with gastrointestinal tract lesions","volume":"45","author":"Rosengelt, F.; Rosenberg, S.A.","year":"1980","unstructured":"Rosengelt F, Rosenberg SA. Diffuse histiocytic lymphoma prcsenting with gastrointestinal tract lesions. Cancer 1980;45:2188.","journal-title":"Cancer"},{"key":"ref_6","first-page":"357","article-title":"Non-Hodgkin's lvmphomas of head and ncck cxtranodal sites. Int j Radtat Oncol Biol","volume":"11","author":"Jacobs, C.; Hoppe, R.T.","year":"1985","unstructured":"Jacobs C, Hoppe RT. Non-Hodgkin's lvmphomas of head and ncck cxtranodal sites. Int j Radtat Oncol Biol Phys 1985;11:357.","journal-title":"Phys"},{"key":"ref_7","first-page":"693","article-title":"IMVP-l6 an effective regimen for patients with lymphoma who have relapsed aftcr initial combination chemotherapy","volume":"50","author":"Cabanillas, F.; Hagenmeister, F.B.; Bodev, G.P.; Freireich, E.J.","year":"1982","unstructured":"Cabanillas F, Hagenmeister FB, Bodev GP, Freireich EJ. IMVP-l6 an effective regimen for patients with lymphoma who have relapsed aftcr initial combination chemotherapy. Blood 1982;50:693.","journal-title":"Blood"},{"issue":"2","key":"ref_8","article-title":"Experience with salvage regimens at M D Anderson Hospital","volume":"1","author":"Cabanillas, F.","year":"1991","unstructured":"Cabanillas F. Experience with salvage regimens at M D Anderson Hospital. Ann Oncol 1991;suppl 1,2:31."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","article-title":"Effective salvage therapy for lymphoma with cisplatin in combination with high dose Ara-C and dexamethasone (DHAP)","volume":"71","author":"Velasquez, W.S.; Cabanillas, F.; Salvador, P.; McLaughlin, P.; Fridrik, M.; Tucker, S.","year":"1988","unstructured":"Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S, et al. Effective salvage therapy for lymphoma with cisplatin in combination with high dose Ara-C and dexamethasone (DHAP). Blood 1988;71: 117.","journal-title":"Blood"},{"key":"ref_10","first-page":"316","article-title":"High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade of high grade non-Hodgkin's lymphoma","volume":"24","author":"Philip, T.; Armitage, J.; Spitzer, G.","year":"1987","unstructured":"Philip T, Armitage J, Spitzer G. High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade of high grade non-Hodgkin's lymphoma. N EnglJ Med 1987;24:316.","journal-title":"N EnglJ Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"4","author":"Coleman, C.N.; Picozzi, V.J.; Cox, R.S.; MIcWhirter, K.; Weis, L.M.; Cohen, JR","year":"1986","unstructured":"Coleman CN, Picozzi VJ, Cox RS, MIcWhirter K, Weis LM, Cohen JR, et al. Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 1986;4:1628.","journal-title":"J Clin Oncol"},{"key":"ref_12","first-page":"1102","article-title":"An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas","volume-title":"children and young adults. Blood","volume":"63","author":"Magrath, I.T.; Janus, C.; Edwards, R.; Spiegal, R.; Jaffe, E.S.; Berard, C.W.","year":"1984","unstructured":"Magrath IT, Janus C, Edwards R, Spiegal R, Jaffe ES, Berard CW, et al. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984;63:1102-11."},{"key":"ref_13","first-page":"583","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclophosphorin-steroid therapy","volume":"i:","author":"Starzl, T.E.; Nalesnik, M.H.; Porter, K.A.; Ho, M.; Iwatsuki, S.; Griffith, B.P.","year":"1984","unstructured":"Starzl TE, Nalesnik MH, Porter KA, Ho M, Iwatsuki S, Griffith BP, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclophosphorin-steroid therapy. Lancet 1984;i:583.","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1182\/blood.V69.6.1617.1617","article-title":"Intermediate lymphocytic lymphoma: immunophenotypic and cytogenic findings","volume":"69","author":"Weisenburger, D.D.; Sanger, W.G.; Armitage, J.O.","year":"1987","unstructured":"Weisenburger DD, Sanger WG, Armitage JO. Intermediate lymphocytic lymphoma: immunophenotypic and cytogenic findings. Blood 1987;69: 1617.","journal-title":"Blood"},{"key":"ref_15","first-page":"155","article-title":"Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sezary syndrome","volume":"1","author":"Kohn, E.C.; Steis, R.G.; Sausville, E.A.","year":"1990","unstructured":"Kohn EC, Steis RG, Sausville EA. Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sezary syndrome. J C\/'in Oncol 1990;1: 155-60.","journal-title":"J C\/'in Oncol"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.305.6844.39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:53:55Z","timestamp":1601117635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.305.6844.39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,7,4]]},"references-count":15,"journal-issue":{"issue":"6844","published-print":{"date-parts":[[1992,7,4]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.305.6844.39","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,7,4]]}}}